BCEIE › News › BLIL

Results

Balmer Lawrie Investments: Unaudited Financial Results (both Standalone and Consolidated ) for the second quarter and half year of…

Balmer Lawrie Investments (BLIL) filed a disclosure titled "Unaudited Financial Results (both Standalone and Consolidated ) for the second quarter and half year of Financial Year 2026-27 ended on 30th September,2026". The company is valued at about ₹1,472…

BCEIE News Desk · Published 10 Nov 2026, 06:53 pm IST · Filing received 10 Nov 2026, 06:37 pm IST

What happened

Balmer Lawrie Investments (BLIL) filed a disclosure with the exchanges on 10 November 2026 at 06:37 PM titled "Unaudited Financial Results (both Standalone and Consolidated ) for the second quarter and half year of Financial Year 2026-27 ended on 30th September,2026".

Company snapshot

Balmer Lawrie Investments is a small-cap company, with a market value of about ₹1,472 crore.

The stock last traded at ₹66.33, against a 52-week range of ₹62–₹79.5 (16.6% below the high).

Before this filing the shares had moved +2.2% over the month and −6.3% over three months. Average daily turnover over the last 20 sessions was about ₹0.44 crore.

Promoters held 59.67% at the end of Q1 FY27. Foreign institutions owned 0.95% and domestic institutions 0.03%.

Quarterly results (standalone, ₹ crore)
QuarterRevenueNet profitEPS (₹)
Q4 FY18—1.20.53
Q1 FY19—1.10.49
Q2 FY19—71.532.18
Q3 FY19—1.70.75
Q4 FY19—1.70.76

What history shows

BCEIE has no earlier results filing from this company on record since May 2026.

Market-wide, 11,356 results filings with an impact score of 50 or more saw an average next-day move of −0.3%, with 43% rising.

Past reactions describe what happened before; they are not a forecast.

What to watch

  • Management commentary, margins and order book or guidance in the investor presentation.

In the news

Recent coverage elsewhere (links open the original publisher):

Source

Automatically written from the exchange filing and BCEIE data. Not investment advice. Check the original filing before acting on it.